Mathematical model forin vivo pharmacodynamics integrating fluctuation of the response: Application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203–922
- 1 June 1991
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 19 (3), 287-309
- https://doi.org/10.1007/bf03036252
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A Non-Gaussian Model for Time Series with PulsesJournal of the American Statistical Association, 1989
- Kinetics of Drug Effects in ManTherapeutic Drug Monitoring, 1988
- Description of the time course of the prolactin suppressant effect of the dopamine agonist CQP201‐403 by an integrated pharmacokinetic‐ pharmacodynamic model.British Journal of Clinical Pharmacology, 1986
- Analysis of pharmacokinetic data using parametric models. II. Point estimates of an individual's parametersJournal of Pharmacokinetics and Biopharmaceutics, 1985
- Pharmacodynamic modeling of thiopental anesthesiaJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Analysis of pharmacokinetic data using parametric models—1: Regression modelsJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- Metabolic clearance and production rates of prolactin in man.JCI Insight, 1979
- Mathematical Basis of Point–Area Deconvolution Method for Determining In Vivo Input FunctionsJournal of Pharmaceutical Sciences, 1978
- Human Prolactin: 24-Hour Pattern with Increased Release during SleepScience, 1972